Safety of canakinumab during pregnancy: seven new cases

Rheumatology (Oxford). 2022 Aug 3;61(8):e229-e231. doi: 10.1093/rheumatology/keac177.
No abstract available

MeSH terms

  • Antibodies, Monoclonal* / adverse effects
  • Antibodies, Monoclonal, Humanized* / adverse effects
  • Female
  • Humans
  • Interleukin-1beta
  • Pregnancy
  • Treatment Outcome

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Interleukin-1beta
  • canakinumab